Last year's EXPERT SPEAKER LINE-UP included:
Essential updates at the 2020 Competition Law in the Pharma Sector:
COVID-19 & Competition Law
Analyse the implications of the COVID-19 pandemic on competition law in the pharma sector including new forms of cooperation, supply chain and distribution models, pricing pressures and the role of industry associations in policy changes.
Mergers in the Pharma Sector
Discuss recent developments in mergers including killer acquisitions, the role of innovation, FDI guidelines, and divestments. Join in-house lawyers to hear their best strategies to address practical problems including gun-jumping.
Global Enforcers’ Roundtable
For the first time in this event's history benefit from an analysis of developments beyond Europe during the global enforcers' roundtable.
Reverse Patent Settlements
Review Paroxetine, Lundbeck and GSK judgements and analyse their practical implications for reverse patent settlements.
Excessive Pricing, Discounts & Rebates
Review recent high-profile cases including UK’s Pfizer/Flynn and investigations into off-patent medicines, as well as recent developments in discounts and rebates including price caps and pricing considerations during the COVID-19 pandemic.
Biologics and Biosimilars
How is the Commission approaching biologics and biosimilars? Should biosimilars be treated in the same way as generics? What are the practical considerations for products entering markets? Gain in-depth insights into these key questions.